Plan and execute efficient syntheses and rapidly deliver targets as an FTE chemist for clients in biotech & pharma industries.

Advanced various medicinal chemistry/chemical biology projects in oncology and neurodegenerative disease fields as a member of Prof. Drew Adams Lab in the Dept. of Genetics-School of Medicine and the Small-Molecule Drug Development Facility.Synthesized a variety of molecules for SAR analysis, MOA determination, and PAL/pulldown target identification purposes.•Modified 8,9-unsaturated cholesterol biosynthesis pathway intermediates and developed inhibitors to elucidate roles in enhanced oligodendrocyte formation towards treatment of demyelination disorders such as multiple sclerosis•Created kinase inhibitor HTS hit derivatives, scaled-up for in vivo studies, and designed target ID probes for treatment of Huntington’s disease•Generated analogs of validated HTS GPT2 inhibitors for treatment of colorectal cancer

Performed NMR experiments and processed data for researchers and customers. Managed and maintained NMR facilities and instruments.

Worked closely with senior materials scientist on the development of improved hollow glass microspheres and their possible applications.